Network origin in Lu Hongbo first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Vivo Co-Invest (S) LP
4
| Subsidiary | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Lu Hongbo via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California. | Investment Managers | Founder Founder Private Equity Investor | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AMYRIS, INC. | Chemicals: Specialty | Director/Board Member | |
| REGENXBIO INC. | Pharmaceuticals: Major | Director/Board Member | |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Director/Board Member | |
| PROCEPT BIOROBOTICS CORPORATION | Medical Specialties | Director/Board Member | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
| Technical University of Denmark | College/University | Graduate Degree | |
ProteinSimple
 ProteinSimple Medical SpecialtiesHealth Technology ProteinSimple engages in the proprietary systems and consumables for protein analysis. Its products include simple plex, ice, simple western, micro-flow imaging, and single-cell western. The company was founded by Linda Cahill, Nancy Allbritton, Christopher Sims, Scott Lockard, and Jim Schlater in December 2000 and is headquartered in San Jose, CA. | Medical Specialties | Director/Board Member | |
| PANACOS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Neomend, Inc.
 Neomend, Inc. BiotechnologyHealth Technology Neomend, Inc. develops surgical wound healing products. It offers adhesion prevention products for hospitals and medical facilities. The company was founded in 1999 and is headquartered in Irvine, CA. | Biotechnology | Director/Board Member | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| SAGENT PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| MERUS N.V. | Biotechnology | Director/Board Member | |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor | |
MacuLogix, Inc.
 MacuLogix, Inc. Medical/Nursing ServicesHealth Services MacuLogix, Inc. engages in the early detection and tracking of retinal diseases. Its AdaptDx is the first practical measurement tool for dark adaptation which provides doctors with an easy-to-use functional test similar to routine perimetry testing for glaucoma. The company also provides macular degeneration services. The company was founded by John G. Edwards and Gregory R. Jackson in 2004 and is headquartered in Harrisburg, PA. | Medical/Nursing Services | Director/Board Member | |
Novo Ventures (US), Inc.
 Novo Ventures (US), Inc. Investment ManagersFinance Novo Ventures (US), Inc. is a venture capital firm located in San Francisco. The firm is a subsidiary of Novo A/S and their ultimate parent is Novo Nordisk Fonden. | Investment Managers | Corporate Officer/Principal | |
| TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director/Board Member | |
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree | |
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Director/Board Member | |
Unchained Labs
 Unchained Labs BiotechnologyHealth Technology Unchained Labs designs, develops, and manufactures tools and devices for biologics research. It sells its products to biopharma and academic customers. The company was founded by Timothy A. Harkness in January 2015 and is headquartered in Pleasanton, CA. | Biotechnology | Director/Board Member | |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Alx Oncology Ltd.
 Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Alx Oncology Ltd. operates as biotechnology company developing immuno-oncology therapies for cancer. The company was founded by Kipp Weiskopf and Jaume Pons in 2015 and is headquartered in Ireland, Dublin. | Pharmaceuticals: Major | Director/Board Member | |
| CRINETICS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Medical/Nursing Services | Founder Director/Board Member | |
| EIGER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| APOLLO ENDOSURGERY, INC. | Medical Specialties | Director/Board Member | |
| Cetus Immune | Founder | ||
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Corporate Officer/Principal | |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Harmony Biosciences LLC
 Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Harmony Biosciences LLC operates as a biopharmaceutical company which develops therapies to help patients with unmet medical needs. It provides novel treatment options to patients with orphan and rare conditions, with an emphasis on central nervous system disorders. The company is headquartered in Plymouth Meeting, PA. | Pharmaceuticals: Major | Director/Board Member | |
| INSTIL BIO, INC. | Biotechnology | Director/Board Member | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
| ALX ONCOLOGY HOLDINGS INC. | Biotechnology | Director/Board Member | |
| IO BIOTECH, INC. | Biotechnology | Director/Board Member | |
Biopharma Holding ApS
 Biopharma Holding ApS Financial ConglomeratesFinance Biopharma Holding ApS functions as a financial holding Danish company. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Chairman |
Statistics
International
| United States | 38 |
| Denmark | 9 |
| Netherlands | 2 |
| China | 2 |
| Switzerland | 2 |
Sectoral
| Health Technology | 37 |
| Finance | 7 |
| Health Services | 4 |
| Consumer Services | 3 |
| Process Industries | 2 |
Operational
| Director/Board Member | 62 |
| Founder | 15 |
| Independent Dir/Board Member | 14 |
| Chairman | 6 |
| Corporate Officer/Principal | 5 |
Most connected contacts
| Insiders | |
|---|---|
| Jack Nielsen | 38 |
| Edgar Engleman | 29 |
| Frank Kung | 22 |
| Michael Chang | 1 |
- Stock Market
- Insiders
- Lu Hongbo
- Company connections
